The University of Oklahoma College of Medicine was founded in 1900 as a medical department of the University of Oklahoma at its main campus in Norman. Lawrence N. Upjohn, M.D. is regarded as the "founding dean" and served from 1900-1904. In 1910, the school merged with the Epworth College of Medicine in Oklahoma City.

During the past decade, University of Oklahoma College of Medicine conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Oklahoma College of Medicine" #1 sponsor was "Gynecologic Oncology Group" with 46 trials, followed by "AltaRex" with 1 trials sponsored, "National Cancer Institute (NCI)" with 1 trials sponsored, "Novartis" with 1 trials sponsored and "Radiation Therapy Oncology Group" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Oklahoma College of Medicine" #1 collaborator was "National Cancer Institute (NCI)" with 47 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Gynecologic Oncology Group" with 1 trials as a collaborator and "SWOG Cancer Research Network" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "University of Oklahoma College of Medicine" are "Ovarian Cancer" (21 trials), "Primary Peritoneal Cavity Cancer" (16 trials), "Endometrial Cancer" (13 trials), "Cervical Cancer" (8 trials) and "Sarcoma" (7 trials). Many other conditions were trialed in "University of Oklahoma College of Medicine" in a lesser frequency.

Most popular intervention types in "University of Oklahoma College of Medicine" are "Drug" (47 trials), "Procedure" (10 trials), "Biological" (7 trials), "Radiation" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (18 trials), "paclitaxel" (12 trials), "radiation therapy" (6 trials), "doxorubicin hydrochloride" (5 trials) and "gemcitabine hydrochloride" (5 trials). Other intervention names were less common.

The vast majority of trials in "University of Oklahoma College of Medicine" are 49 trials for "Female" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "University of Oklahoma College of Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in University of Oklahoma College of Medicine, undefined suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in University of Oklahoma College of Medicine, 4 "Phase 1" clinical trials were conducted, 32 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".